Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3140 (LINC03140)

Target
LINC03140
Molecular classification
Long non-coding RNA (lncRNA), Intergenic long non-coding RNA (lincRNA), Chromatin modification-associated lncRNA
01

Overview

Long intergenic non-protein coding RNA 3140 (LINC03140), referred to as lincRNA-JADE or lncRNA-JADE, is a regulatory non-coding RNA located in a genomic desert between protein-coding genes[2]. It has a critical role in transcriptional activation of Jade1, a key factor in histone acetylation, particularly during the DNA damage response. lincRNA-JADE interacts with BRCA1 and contributes to recruitment of coactivators, positively regulating histone H4 acetylation and, consequently, influencing gene expression. In pathological contexts, such as breast cancer, lincRNA-JADE is upregulated and appears to facilitate cancer cell proliferation, suggesting a modulatory—rather than direct—role in disease biology[1][2].

Other names
lincRNA-JADE1lncRNA-JADELINC03140
02

Mechanism of action

Not applicable, as there are no drugs with a defined mechanism acting on this RNA. Its role is as a regulator influencing chromatin acetylation and gene transcription[1][2].

03

Biological functions

Transcriptional activation of adjacent genes, especially Jade1Modulation of histone H4 acetylation via the HBO1 complexRegulation of DNA damage response by interacting with BRCA1 and recruiting coactivator complexesPromoting cell proliferation and survival in cancer settings
04

Disease associations

Cancer (particularly breast cancer; upregulation noted in tumors)Tumorigenesis and regulation of proliferation-promoting genesPotential involvement in DNA repair and cell cycle regulation
05

Safety considerations

None established, but potential challenges include off-target effects in therapies attempting to modulate non-coding RNAs and systemic chromatin regulation
06

Biomarkers

Expression of lincRNA-JADE has potential biomarker value for breast cancer prognosis, reflecting the proliferative state of tumors

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3140 (LINC03140).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3140 (LINC03140).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call